Kaleido

Biosciences is a healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health...
Read more
Kaleido President & CEO: Daniel Menichella

President & CEO

Daniel Menichella

CEO Approval Rating

90/100

Annual Revenue
$1.1M
Employees
80
Funding
$226.4M

Kaleido Competitors

1Evelo
2Seres Therapeutics
3Synlogic
4Second Genome
5Vedanta
6Axcella
7PanTheryx
8BiomeSense
9Biosortia
10Finch

Trending Companies